These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34893641)

  • 1. The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression.
    Li X; Yuan B; Lu M; Wang Y; Ding N; Liu C; Gao M; Yao Z; Zhang S; Zhao Y; Xie L; Chen Z
    Nat Commun; 2021 Dec; 12(1):7213. PubMed ID: 34893641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH).
    Li X; Ding K; Li X; Yuan B; Wang Y; Yao Z; Wang S; Huang H; Xu B; Xie L; Deng T; Chen XW; Chen Z
    Nat Commun; 2022 Aug; 13(1):4549. PubMed ID: 35927268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
    Zhu H; Zhao T; Zhao S; Yang S; Jiang K; Li S; Kang Y; Yang Z; Shen J; Shen S; Tao H; Xuan J; Yang M; Xu B; Wang F; Jiang M
    Metabolism; 2024 Jul; 156():155914. PubMed ID: 38642829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
    Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7.
    Yang S; Jia L; Xiang J; Yang G; Qiu S; Kang L; Zheng P; Liang Z; Lu Y
    EMBO Rep; 2022 Jun; 23(6):e54229. PubMed ID: 35492028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo.
    Bai YP; Zhang T; Hu ZY; Zhang Y; Wang DG; Zhou MY; Zhang Y; Zhang F; Kong X
    Biochem Pharmacol; 2024 Jun; 224():116240. PubMed ID: 38679210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
    Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.
    Li Y; Zhang L; Jiao J; Ding Q; Li Y; Zhao Z; Luo J; Chen Y; Ruan X; Zhao L
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166800. PubMed ID: 37423141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV; Diehl AM
    Gastroenterology; 2016 Jun; 150(8):1769-77. PubMed ID: 26928243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2.
    Liu B; Xiang L; Ji J; Liu W; Chen Y; Xia M; Liu Y; Liu W; Zhu P; Jin Y; Han Y; Lu J; Li X; Zheng M; Lu Y
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34651580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis.
    Xiao Y; Batmanov K; Hu W; Zhu K; Tom AY; Guan D; Jiang C; Cheng L; McCright SJ; Yang EC; Lanza MR; Liu Y; Hill DA; Lazar MA
    Sci Transl Med; 2023 Feb; 15(682):eadc9653. PubMed ID: 36753562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis.
    Kang J; Postigo-Fernandez J; Kim K; Zhu C; Yu J; Meroni M; Mayfield B; Bartolomé A; Dapito DH; Ferrante AW; Dongiovanni P; Valenti L; Creusot RJ; Pajvani UB
    JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
    Rada P; González-Rodríguez Á; García-Monzón C; Valverde ÁM
    Cell Death Dis; 2020 Sep; 11(9):802. PubMed ID: 32978374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.